HeartBeam Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Rob Eno
Chief executive officer
US$2.6m
Total compensation
| CEO salary percentage | 13.5% |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | less than a year |
| Board average tenure | 1.5yrs |
Recent management updates
Recent updates
Here's Why We're Watching HeartBeam's (NASDAQ:BEAT) Cash Burn Situation
Sep 19
Companies Like HeartBeam (NASDAQ:BEAT) Could Be Quite Risky
Jan 17HeartBeam gets a new chief medical officer
Oct 11HeartBeam gets patent to enable generation of its credit card-sized ECG, shares rise ~15%
Sep 28HeartBeam surges 54% on U.S. patent for ECG patch monitor to detect heart attacks
Sep 15HeartBeam GAAP EPS of $0.43 beats by $0.70
Aug 11HeartBeam: Cardiovascular Diagnostics On The Go
Dec 14CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$18m |
| Jun 30 2024 | n/a | n/a | -US$17m |
| Mar 31 2024 | n/a | n/a | -US$15m |
| Dec 31 2023 | US$3m | US$345k | -US$15m |
Compensation vs Market: Rob's total compensation ($USD2.55M) is above average for companies of similar size in the US market ($USD651.40K).
Compensation vs Earnings: Insufficient data to compare Rob's compensation with company performance.
CEO
Rob Eno
less than a year
Tenure
US$2,552,204
Compensation
Mr. Robert P. Eno, also known as Rob, is Chief Executive Officer of HeartBeam, Inc. since October 21, 2024 and serves as its Chief Business Officer and was President from January 18, 2023 to October 21, 20...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 5.9yrs | US$238.59k | 0.64% $ 409.0k | |
| CEO & Chief Business Officer | less than a year | US$2.55m | no data | |
| Founder | less than a year | US$3.25m | 3.42% $ 2.2m | |
| Chief Technology Officer | 2.3yrs | US$1.41m | 0% $ 0 | |
| Chief Financial Officer | less than a year | no data | no data | |
| Member of Scientific Advisory Board & Chief Medical Officer | 2.2yrs | no data | no data | |
| Senior Vice President of Product | 1.3yrs | no data | no data |
0.8yrs
Average Tenure
68yo
Average Age
Experienced Management: BEAT's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 5.9yrs | US$238.59k | 0.64% $ 409.0k | |
| Founder | no data | US$3.25m | 3.42% $ 2.2m | |
| Member of Scientific Advisory Board & Chief Medical Officer | 1.1yrs | no data | no data | |
| Independent Director | 1.5yrs | US$104.72k | 1.03% $ 654.8k | |
| Independent Director | no data | US$152.50k | 0.090% $ 57.3k | |
| Independent Director | 1.4yrs | US$148.65k | 0.052% $ 33.4k | |
| Independent Director | no data | US$140.64k | 1.47% $ 936.0k | |
| Member of Scientific Advisory Board | 1.1yrs | no data | no data | |
| Independent Director | no data | US$140.00k | 0.36% $ 229.3k | |
| Chairman of Scientific Advisory Board | 2.9yrs | no data | no data | |
| Independent Director | 1.5yrs | US$102.60k | 0.35% $ 224.6k | |
| Member of Scientific Advisory Board | 1.1yrs | no data | no data |
1.5yrs
Average Tenure
66.5yo
Average Age
Experienced Board: BEAT's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 02:55 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
HeartBeam, Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Benjamin Haynor | Alliance Global Partners |
| William Sutherland | Benchmark Company |
| Leo Carpio | Joseph Gunnar & Co., LLC |